Jai Murthy Appointed Vice President and Business Manager for Global Pharmaceuticals
Avantor Performance Materials (Pennsylvania, USA) has appointed Jai Murthy as Vice President and Business Manager, Global Pharmaceuticals. Murthy will work within the pharmaceutical chemicals business unit to expand and develop global sales programs, business initiatives to expand the company?s presence in existing and new markets.
Avantor Performance Materials (Pennsylvania, USA) has appointed Jai Murthy as Vice President and Business Manager, Global Pharmaceuticals. Murthy will work within the pharmaceutical chemicals business unit to expand and develop global sales programs, business initiatives to expand the company’s presence in existing and new markets.
Murthy holds a bachelor’s degree in biology from the University of Texas (Texas, USA) and a doctorate in molecular and cellular biology from Harvard University. He has co-authored publications in the areas of molecular genetics, population genetics, and human and animal genomics.
Murthy has an extensive background and expertise in the health care and life sciences industries. He has previously worked in various R&D roles in early-stage molecular genetics companies, as well as market development at Beckman Coulter. He joined Thermo Fisher Scientific in a global product management role, before becoming responsible for leading the company’s supplier strategy in Asia Pacific.
For more information please visit www.avantormaterials.com
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.
